首页> 外文期刊>Journal of biomedicine & biotechnology >Differential Control of Growth, Apoptotic Activity, and Gene Expression in Human Breast Cancer Cells by Extracts Derived from Medicinal Herbs Zingiber officinale
【24h】

Differential Control of Growth, Apoptotic Activity, and Gene Expression in Human Breast Cancer Cells by Extracts Derived from Medicinal Herbs Zingiber officinale

机译:药用姜提取物对人乳腺癌细胞生长,凋亡活性和基因表达的差异控制

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

The present study aimed to examine the antiproliferative potentiality of an extract derived from the medicinal plant ginger {Zingiber officinale) on growth of breast cancer cells. Ginger treatment suppressed the proliferation and colony formation in breast cancer cell lines, MCF-7 and MDA-MB-231. Meanwhile, it did not significantly affect viability of nontumorigenic normal mammary epithelial cell line (MCF-10A). Treatment of MCF-7 and MDA-MB-231 with ginger resulted in sequences of events marked by apoptosis, accompanied by loss of cell viability, chromatin condensation, DNA fragmentation, activation of caspase 3, and cleavage of poly(ADP-ribose) polymerase. At the molecular level, the apoptotic cell death mediated by ginger could be attributed in part to upregulation of Bax and downregulation of Bcl-2 proteins. Ginger treatment downregulated expression of prosurvival genes, such as NF-kB, Bcl-X, Mcl-1, and Survivin, and cell cycle-regulating proteins, including cyclin Dl and cyclin-dependent kinase-4 (CDK-4), On the other hand, it increased expression of CDK inhibitor, p21. It also inhibited the expression of the two prominent molecular targets of cancer, c-Myc and the human telomerase reverse transcriptase (hTERT). These findings suggested that the ginger may be a promising candidate for the treatment of breast carcinomas.
机译:本研究旨在检查药用植物生姜(Zingiber officinale)提取物对乳腺癌细胞生长的抑制作用。生姜治疗抑制了乳腺癌细胞MCF-7和MDA-MB-231的增殖和集落形成。同时,它没有显着影响非致瘤性正常乳腺上皮细胞系(MCF-10A)的生存能力。用生姜处理MCF-7和MDA-MB-231会导致一系列以细胞凋亡为特征的事件,伴随着细胞活力的丧失,染色质浓缩,DNA片段化,胱天蛋白酶3的活化以及聚ADP-核糖聚合酶的裂解。在分子水平上,姜介导的凋亡细胞死亡可能部分归因于Bax的上调和Bcl-2蛋白的下调。生姜治疗下调了生存基因(例如NF-kB,Bcl-X,Mcl-1和Survivin)以及细胞周期调节蛋白(包括细胞周期蛋白D1和细胞周期蛋白依赖性激酶4(CDK-4))的表达。另一方面,它增加了CDK抑制剂p21的表达。它还抑制了癌症的两个重要分子靶标c-Myc和人类端粒酶逆转录酶(hTERT)的表达。这些发现表明,生姜可能是治疗乳腺癌的有前途的候选药物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号